{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:32:01Z","timestamp":1790742721491,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jaci.2009.06.036","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T04:09:55Z","timestamp":1249790995000},"page":"1070-1077.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Immunize and disappear\u2014Safety-optimized mRNA vaccination with a panel of 29 allergens"],"prefix":"10.1016","volume":"124","author":[{"given":"Elisabeth","family":"Roesler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Fruehwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Stoecklinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mostb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Thalhamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Scheiblhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.06.036_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1398-9995.2006.01293.x","article-title":"Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2009.06.036_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000236836","article-title":"Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults","volume":"106","author":"Wuthrich","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.immunol.18.1.347","article-title":"Molecular genetics of allergic diseases","volume":"18","author":"Ono","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib4","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0140-6736(96)91617-7","article-title":"Measles and atopy in Guinea-Bissau","volume":"347","author":"Shaheen","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2009.06.036_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1365-2222.2000.00959.x","article-title":"Exposure to endotoxin or other bacterial components might protect against the development of atopy","volume":"30","author":"von Mutius","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2009.06.036_bib6","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2","article-title":"Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy","volume":"29","author":"Ball","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2222.1997.tb00674.x","article-title":"Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy","volume":"27","author":"Van Ree","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2009.06.036_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000091946","article-title":"Is genetic vaccination against allergy possible?","volume":"139","author":"Weiss","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib10","first-page":"261","article-title":"DNA vaccines: safety aspect assessment and regulation","volume":"126","author":"Medjitna","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.jaci.2009.06.036_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-6749(98)70137-X","article-title":"The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB\/c mice of its DNA vaccine","volume":"102","author":"Slater","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3302964","article-title":"Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent","volume":"14","author":"Probst","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.jaci.2009.06.036_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer therapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2009.06.036_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jaci.2006.04.048","article-title":"Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization","volume":"118","author":"Gabler","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymeth.2003.08.014","article-title":"DNA vaccines for allergy treatment","volume":"32","author":"Hartl","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.jaci.2009.06.036_bib16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/eji.200323377","article-title":"Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen","volume":"33","author":"Hochreiter","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2006.03.033","article-title":"Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy","volume":"118","author":"Bauer","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1164\/ajrccm.156.3.9606031","article-title":"Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography","volume":"156","author":"Hamelmann","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2009.06.036_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(01)06252-3","article-title":"Exposure to farming in early life and development of asthma and allergy: a\u00a0cross-sectional survey","volume":"358","author":"Riedler","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2009.06.036_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2003.11.025","article-title":"Immunologic influences on allergy and the TH1\/TH2 balance","volume":"113","author":"Romagnani","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1398-9995.2006.01142.x","article-title":"Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines","volume":"61","author":"Scheiblhofer","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2009.06.036_bib22","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.molimm.2006.09.023","article-title":"Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy","volume":"44","author":"Scheiblhofer","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib23","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.vaccine.2003.10.013","article-title":"Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines","volume":"22","author":"Leitner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2009.06.036_bib24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14712598.4.8.1285","article-title":"Messenger RNA-based vaccines","volume":"4","author":"Pascolo","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaci.2009.06.036_bib25","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00018-004-4255-0","article-title":"Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines","volume":"61","author":"Carralot","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2009.06.036_bib26","first-page":"555","article-title":"Replicon-based vectors of positive strand RNA viruses","volume":"2","author":"Khromykh","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.jaci.2009.06.036_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1471-4906(03)00121-2","article-title":"Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms","volume":"24","author":"von Herrath","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1165\/rcmb.2004-0128OC","article-title":"Upregulation of interleukin-4 receptor by interferon-gamma: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium","volume":"31","author":"Yamamoto","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2009.06.036_bib29","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.167.3.1769","article-title":"Il-13 and IFN-gamma: interactions in lung inflammation","volume":"167","author":"Ford","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaci.2007.11.028","article-title":"Use of unrestrained, single-chamber barometric plethysmography to evaluate sensitivity to cholinergic stimulation in mouse models of allergic airway disease","volume":"121","author":"Finkelman","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib31","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/eji.1830271027","article-title":"Antigen-specific CD8+ T cells inhibit IgE responses and interleukin-4 production by CD4+ T cells","volume":"27","author":"Holmes","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.152.1.351","article-title":"Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization","volume":"152","author":"Renz","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaci.2006.09.004","article-title":"Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration","volume":"119","author":"Wells","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.036_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/gt.2008.164","article-title":"Reis e Sousa C. Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines","volume":"16","author":"Diebold","year":"2009","journal-title":"Gene Ther"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909009907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909009907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:19:22Z","timestamp":1758788362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674909009907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0091674909009907"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.06.036","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunize and disappear\u2014Safety-optimized mRNA vaccination with a panel of 29 allergens","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}